{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T13:49:15Z","timestamp":1788961755174,"version":"build-2803163510"},"reference-count":70,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T00:00:00Z","timestamp":1621987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008483","name":"NOMIS Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008933","name":"Fondation Gaydoul","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008933","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008494","name":"Vontobel-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008494","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Following the spread of the coronavirus disease 2019 (COVID-19) pandemic a new disease entity emerged, defined as Pediatric Inflammatory Multisystem Syndrome temporally associated with COVID-19 (PIMS-TS), or Multisystem Inflammatory Syndrome in Children (MIS-C). In the absence of trials, evidence for treatment remains scarce.<\/jats:p><jats:p><jats:bold>Purpose:<\/jats:bold> To develop best practice recommendations for the diagnosis and treatment of children with PIMS-TS in Switzerland. It is acknowledged that the field is changing rapidly, and regular revisions in the coming months are pre-planned as evidence is increasing.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Consensus guidelines for best practice were established by a multidisciplinary group of Swiss pediatric clinicians with expertise in intensive care, immunology\/rheumatology, infectious diseases, hematology, and cardiology. Subsequent to literature review, four working groups established draft recommendations which were subsequently adapted in a modified Delphi process. Recommendations had to reach &amp;gt;80% agreement for acceptance.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The group achieved agreement on 26 recommendations, which specify diagnostic approaches and interventions across anti-inflammatory, anti-infectious, and support therapies, and follow-up for children with suspected PIMS-TS. A management algorithm was derived to guide treatment depending on the phenotype of presentation, categorized into PIMS-TS with (a) shock, (b) Kawasaki-disease like, and (c) undifferentiated inflammatory presentation.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Available literature on PIMS-TS is limited to retrospective or prospective observational studies. Informed by these cohort studies and indirect evidence from other inflammatory conditions in children and adults, as well as guidelines from international health authorities, the Swiss PIMS-TS recommendations represent best practice guidelines based on currently available knowledge to standardize treatment of children with suspected PIMS-TS. Given the absence of high-grade evidence, regular updates of the recommendations will be warranted, and participation of patients in trials should be encouraged.<\/jats:p>","DOI":"10.3389\/fped.2021.667507","type":"journal-article","created":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T05:03:45Z","timestamp":1622005425000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":71,"title":["Best Practice Recommendations for the Diagnosis and Management of Children With Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (PIMS-TS; Multisystem Inflammatory Syndrome in Children, MIS-C) in Switzerland"],"prefix":"10.3389","volume":"9","author":[{"given":"Luregn J.","family":"Schlapbach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya C.","family":"Andre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Grazioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Sch\u00f6bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Ritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Aebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Agyeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Albisetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douggl G. N.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9raldine","family":"Blanchard-Rohner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Bressieux-Degueldre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud G.","family":"L'Huillier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Marston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Meyer Sauteur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Pachlopnik Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Helene","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjarte","family":"Rogdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Tr\u00fcck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Woerner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"W\u00fctz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Whittaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Rimensberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the PIMS-TS working group of the Interest Group for Pediatric Neonatal Intensive Care (IGPNI) of the Swiss Society of Intensive Care and the Pediatric Infectious Diseases Group Switzerland (PIGS)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1056\/NEJMcp2009575","article-title":"Severe Covid-19","volume":"383","author":"Berlin","year":"2020","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMe2023158","article-title":"Childhood multisystem inflammatory syndrome - a new challenge in the pandemic","volume":"383","author":"Levin","year":"2020","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/PCC.0000000000002599","article-title":"Neonatal intensive care scientific sections' collaborative, caring for critically ill children with suspected or proven coronavirus disease 2019 infection: recommendations by the scientific sections' collaborative of the European Society of Pediatric and Neonatal Intensive Care","volume":"22","author":"Rimensberger","year":"2021","journal-title":"Pediatr Crit Care Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1001\/jama.2020.10369","article-title":"Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2","volume":"324","author":"Whittaker","year":"2020","journal-title":"JAMA."},{"key":"B5","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1056\/NEJMoa2021680","article-title":"Multisystem inflammatory syndrome in U.S. children and adolescents","volume":"383","author":"Feldstein","year":"2020","journal-title":"N Engl J Med."},{"key":"B6","unstructured":"Guidance: Paediatric Multisystem Inflammatory Syndrome Temporally Associated With COVID-192020"},{"key":"B7","unstructured":"2020"},{"key":"B8","unstructured":"Multisystem Inflammatory Syndrome in Children and Adolescents With COVID-192020"},{"key":"B9","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s00134-020-06273-2","article-title":"Paediatric inflammatory multisystem syndrome temporally-associated with SARS-CoV-2 infection: an overview","volume":"47","author":"Carter","year":"2021","journal-title":"Intensive Care Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"100527","DOI":"10.1016\/j.eclinm.2020.100527","article-title":"Multisystem inflammatory syndrome in children: a systematic review","volume":"26","author":"Ahmed","year":"2020","journal-title":"EClinicalMedicine."},{"key":"B11","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.cell.2020.09.034","article-title":"Mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children (MIS-C)","volume":"183","author":"Gruber","year":"2020","journal-title":"Cell."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1038\/s41591-020-1054-6","article-title":"Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection","volume":"26","author":"Carter","year":"2020","journal-title":"Nat Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"5942","DOI":"10.1172\/JCI141113","article-title":"Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children","volume":"130","author":"Lee","year":"2020","journal-title":"J Clin Invest."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piaa142","article-title":"Immunological assessment of pediatric multisystem inflammatory syndrome related to COVID-19","author":"Grazioli","year":"2020","journal-title":"J Pediatric Infect Dis Soc"},{"key":"B15","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.cell.2020.09.016","article-title":"The immunology of multisystem inflammatory syndrome in children with COVID-19","volume":"183","author":"Consiglio","year":"2020","journal-title":"Cell."},{"key":"B16","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41577-020-0367-5","article-title":"Understanding SARS-CoV-2-related multisystem inflammatory syndrome in children","volume":"20","author":"Rowley","year":"2020","journal-title":"Nat Rev Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1111\/jth.15073","article-title":"Consensus-based clinical recommendations and research priorities for anticoagulant thromboprophylaxis in children hospitalized for COVID-19-related illness","volume":"18","author":"Goldenberg","year":"2020","journal-title":"J Thromb Haemost."},{"key":"B18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1161\/CIRCULATIONAHA.120.049836","article-title":"Review of cardiac involvement in multisystem inflammatory syndrome in children","volume":"143","author":"Alsaied","year":"2021","journal-title":"Circulation."},{"key":"B19","doi-asserted-by":"publisher","first-page":"626182","DOI":"10.3389\/fped.2020.626182","article-title":"Multisystem inflammatory syndrome in children (MIS-C), a post-viral myocarditis and systemic vasculitis-a critical review of its pathogenesis and treatment","volume":"8","author":"McMurray","year":"2020","journal-title":"Front Pediatr."},{"key":"B20","doi-asserted-by":"publisher","first-page":"m3979","DOI":"10.1136\/bmj.m3979","article-title":"Covid-19's known unknowns","volume":"371","author":"Davey Smith","year":"2020","journal-title":"BMJ."},{"key":"B21","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3389\/fped.2020.00490","article-title":"Pediatric inflammatory multisystem syndrome: statement by the pediatric section of the European Society for Emergency Medicine and European Academy of Pediatrics","volume":"8","author":"Nijman","year":"2020","journal-title":"Front Pediatrics"},{"key":"B22","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1136\/annrheumdis-2020-217960","article-title":"Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort","volume":"79","author":"Pouletty","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e2020024554","DOI":"10.1542\/peds.2020-024554","article-title":"Multisystem inflammatory syndrome in children: an international survey","volume":"147","author":"Bautista-Rodriguez","year":"2021","journal-title":"Pediatrics."},{"key":"B24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1101\/2020.07.29.20164459","article-title":"Multisystem inflammatory syndrome in children: survey of protocols for early hospital evaluation and management","volume":"229","author":"Dove","year":"2021","journal-title":"J Pediatr."},{"key":"B25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S2352-4642(20)30304-7","article-title":"A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process","volume":"5","author":"Harwood","year":"2021","journal-title":"Lancet Child Adolesc Health."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e178","DOI":"10.1097\/PCC.0000000000002598","article-title":"Multisystem inflammatory syndrome in children associated with coronavirus disease 2019 in a children's hospital in New York city: patient characteristics and an institutional protocol for evaluation, management, and follow-up","volume":"22","author":"Jonat","year":"2021","journal-title":"Pediatr Crit Care Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00431-020-03766-6","article-title":"Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach","volume":"180","author":"Sperotto","year":"2021","journal-title":"Eur J Pediatr."},{"key":"B28","unstructured":"American Academy of PediatricsMultisystem Inflammatory Syndrome in Children (MIS-C) Interim Guidance2020"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/01.PCC.0000149131.72248.E6","article-title":"International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics","volume":"6","author":"Goldstein","year":"2005","journal-title":"Pediatr Crit Care Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation."},{"key":"B31","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1101\/2020.07.17.20156075","article-title":"A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process","volume":"5","author":"Harwood","year":"2020","journal-title":"Lancet Child Adolesc Health"},{"key":"B32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2139\/ssrn.3634853","article-title":"Acute cardiovascular manifestations in 286 children with multisystem inflammatory syndrome associated with COVID-19 infection in Europe","volume":"143","author":"Valverde","year":"2021","journal-title":"Circulation."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1136\/archdischild-2020-319554","article-title":"Paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): the Evelina Experience","volume":"105","author":"White","year":"2020","journal-title":"Arch Dis Child."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e1031","DOI":"10.1097\/PCC.0000000000002553","article-title":"Perspective of the surviving sepsis campaign on the management of pediatric sepsis in the era of coronavirus disease 2019","volume":"21","author":"Weiss","year":"2020","journal-title":"Pediatr Crit Care Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e2020009738","DOI":"10.1542\/peds.2020-009738","article-title":"MIS-C and cardiac conduction abnormalities","volume":"146","author":"Choi","year":"2020","journal-title":"Pediatrics."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e2020009704","DOI":"10.1542\/peds.2020-009704","article-title":"Atrioventricular block in children with multisystem inflammatory syndrome","volume":"146","author":"Dionne","year":"2020","journal-title":"Pediatrics."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1016\/j.jacc.2020.08.056","article-title":"Echocardiographic findings in pediatric multisystem inflammatory syndrome associated with COVID-19 in the United States","volume":"76","author":"Matsubara","year":"2020","journal-title":"J Am Coll Cardiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/S0140-6736(20)31094-1","article-title":"Hyperinflammatory shock in children during COVID-19 pandemic","volume":"395","author":"Riphagen","year":"2020","journal-title":"Lancet"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/S0140-6736(20)31103-X","article-title":"An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study","volume":"395","author":"Verdoni","year":"2020","journal-title":"Lancet."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1002\/art.41454","article-title":"American College of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 1","volume":"72","author":"Henderson","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/rheumatology\/key344","article-title":"European consensus-based recommendations for the diagnosis and treatment of Kawasaki disease - the SHARE initiative","volume":"58","author":"de Graeff","year":"2019","journal-title":"Rheumatology."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1161\/CIRCULATIONAHA.120.050147","article-title":"Addition of corticosteroids to immunoglobulins is associated with recovery of cardiac function in multi-inflammatory syndrome in children","volume":"142","author":"Belhadjer","year":"2020","journal-title":"Circulation."},{"key":"B43","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1001\/jama.2021.0694","article-title":"Association of intravenous immunoglobulins plus methylprednisolone vs immunoglobulins alone with course of fever in multisystem inflammatory syndrome in children","volume":"325","author":"Ouldali","year":"2021","journal-title":"JAMA."},{"key":"B44","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/PCC.0b013e3181b806fc","article-title":"Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass","volume":"11","author":"Gaies","year":"2010","journal-title":"Pediatr Crit Care Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"594127","DOI":"10.3389\/fped.2020.594127","article-title":"Case report: case series of children with multisystem inflammatory syndrome following SARS-CoV-2 infection in Switzerland","volume":"8","author":"Fouriki","year":"2020","journal-title":"Front Pediatr."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e358","DOI":"10.1016\/S2665-9913(20)30096-5","article-title":"Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome","volume":"2","author":"Mehta","year":"2020","journal-title":"Lancet Rheumatol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/jcbfm.2010.103","article-title":"Intravenous anakinra can achieve experimentally effective concentrations in the central nervous system within a therapeutic time window: results of a dose-ranging study","volume":"31","author":"Galea","year":"2011","journal-title":"J Cereb Blood Flow Metab."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1038\/s41591-020-1140-9","article-title":"The immune roadmap for understanding multi-system inflammatory syndrome in children: opportunities and challenges","volume":"26","author":"Martinez","year":"2020","journal-title":"Nat Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"5967","DOI":"10.1172\/JCI140970","article-title":"Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2","volume":"130","author":"Diorio","year":"2020","journal-title":"J Clin Invest."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19 - final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N Engl J Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"m2924","DOI":"10.1136\/bmj.m2924","article-title":"Remdesivir for severe covid-19: a clinical practice guideline","volume":"370","author":"Rochwerg","year":"2020","journal-title":"BMJ."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e274","DOI":"10.1111\/bjh.17014","article-title":"Remdesivir during induction chemotherapy for newly diagnosed paediatric acute lymphoblastic leukaemia with concomitant SARS-CoV-2 infection","volume":"190","author":"Orf","year":"2020","journal-title":"Br J Haematol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/jpids\/piaa045","article-title":"Multicenter interim guidance on use of antivirals for children with COVID-19\/SARS-CoV-2","volume":"10","author":"Chiotos","year":"2020","journal-title":"J Pediatric Infect Dis Soc"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1001\/jama.2020.6019","article-title":"Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review","volume":"323","author":"Sanders","year":"2020","journal-title":"JAMA."},{"key":"B57","unstructured":"Fact sheet for healthcare providers emergency use authorization (EUA) of veklury\u00ae (remdesivir) for hospitalized pediatric patients weighing 3.5 kg to less than 40 kg or hospitalized pediatric patients less than 12 years of age weighing at least 3.5 KG2020"},{"key":"B58","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/QCO.0000000000000583","article-title":"Paediatric sepsis","volume":"32","author":"Schlapbach","year":"2019","journal-title":"Curr Opin Infect Dis"},{"key":"B59","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1001\/jamapediatrics.2017.5208","article-title":"Defining pediatric sepsis","volume":"172","author":"Schlapbach","year":"2018","journal-title":"JAMA Pediatr."},{"key":"B60","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s00134-019-05878-6","article-title":"Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children","volume":"46","author":"Weiss","year":"2020","journal-title":"Intensive Care Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1001\/jama.2018.9071","article-title":"Association between the New York sepsis care mandate and in-hospital mortality for pediatric sepsis","volume":"320","author":"Evans","year":"2018","journal-title":"JAMA."},{"key":"B62","doi-asserted-by":"publisher","first-page":"6051","DOI":"10.1182\/bloodadvances.2020003471","article-title":"Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations","volume":"4","author":"Diorio","year":"2020","journal-title":"Blood Adv."},{"key":"B63","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/MOP.0000000000000084","article-title":"Venous thromboembolism in critically ill children","volume":"26","author":"Polikoff","year":"2014","journal-title":"Curr Opin Pediatr."},{"key":"B64","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/INF.0000000000002949","article-title":"COVID-19 and multisystem inflammatory syndrome in latin american children: a multinational study","volume":"40","author":"Antunez-Montes","year":"2021","journal-title":"Pediatr Infect Dis J."},{"key":"B65","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1186\/s13054-020-03332-4","article-title":"Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain","volume":"24","author":"Garcia-Salido","year":"2020","journal-title":"Crit Care."},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1719173","article-title":"Clinicolaboratory profile, treatment, intensive care needs, and outcome of pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2: a systematic review and meta-analysis","author":"Williams","year":"2020","journal-title":"J Pediatric Intensive Care"},{"key":"B67","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jpeds.2020.06.045","article-title":"Multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2 infection (MIS-C): a multi-institutional study from New York city","volume":"224","author":"Kaushik","year":"2020","journal-title":"J Pediatr."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/cid\/ciaa885","article-title":"Coronavirus disease 2019 (COVID-19) pharmacologic treatments for children: research priorities and approach to pediatric studies","volume":"72","author":"Garcia-Prats","year":"2021","journal-title":"Clin Infect Dis."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21645515.2020.1834325","article-title":"Factors associated with parents' willingness to enroll their children in trials for COVID-19 vaccination","volume":"17","author":"Goldman","year":"2020","journal-title":"Hum Vaccin Immunother."},{"key":"B70","doi-asserted-by":"publisher","first-page":"e20201081","DOI":"10.1542\/peds.2020-1081","article-title":"A call for pediatric COVID-19 clinical trials","volume":"146","author":"Campbell","year":"2020","journal-title":"Pediatrics."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.667507\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T05:03:52Z","timestamp":1622005432000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.667507\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,26]]},"references-count":70,"alternative-id":["10.3389\/fped.2021.667507"],"URL":"https:\/\/doi.org\/10.3389\/fped.2021.667507","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,26]]},"article-number":"667507"}}